The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
listen i still think fibrates are widely underused drug i think for the right person where you've through whatever method you use have identified triglyceride rich lipoproteins perhaps those where you clearly see insulin resistance their diabetics or their insulin levels are high that's where the fibre sub trial analysis shows miraculous things not only with macrovascular endpoints but with microvascular endpoints retina peripheral nervous system renal function
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.